Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | 0.00% | -9.52% | -45.71% |
22/05 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
20/05 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.71% | 1.1Cr | |
+15.55% | 12TCr | |
+12.66% | 11TCr | |
-2.53% | 2.48TCr | |
+0.90% | 2.25TCr | |
-9.58% | 1.83TCr | |
-42.28% | 1.63TCr | |
-18.92% | 1.53TCr | |
+6.19% | 1.41TCr | |
+28.83% | 1.17TCr |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Completes Share Purchase Plan; Shares Rise 6%